|
Volumn 49, Issue 4, 2015, Pages 469-476
|
Radium-223 Dichloride: A Novel Treatment Option for Castration-Resistant Prostate Cancer Patients With Symptomatic Bone Metastases
|
Author keywords
adult medicine; cancer; clinical decision making; drug development and approval; drug trials; education; oncology; radioisotopes; supportive care
|
Indexed keywords
RADIUM CHLORIDE RA 223;
ANTINEOPLASTIC AGENT;
RADIOISOTOPE;
RADIUM;
AREA UNDER THE CURVE;
BONE METASTASIS;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CASTRATION RESISTANT PROSTATE CANCER;
CHEMOTHERAPY INDUCED ANEMIA;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
CLINICAL DECISION MAKING;
DIARRHEA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG SAFETY;
FEBRILE NEUTROPENIA;
HEALTH CARE QUALITY;
HUMAN;
LYMPHOCYTOPENIA;
MAINTENANCE THERAPY;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
PERIPHERAL EDEMA;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIOACTIVITY;
REVIEW;
THROMBOCYTOPENIA;
BONE NEOPLASMS;
FOOD AND DRUG ADMINISTRATION;
PATHOLOGY;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SECONDARY;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
HUMANS;
MALE;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
RADIOISOTOPES;
RADIUM;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84924915161
PISSN: 10600280
EISSN: 15426270
Source Type: Journal
DOI: 10.1177/1060028014565444 Document Type: Review |
Times cited : (19)
|
References (15)
|